<?xml version="1.0" encoding="UTF-8"?>
<results title="test_trace">
 <result pre="coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and" exact="treatment" post="KangShuntongabPengWenyaoabZhuYuhaoabLuShiyaoabZhouMinabLinWeiaWuWenfangaHuangShuaJiangLipingcLuoXuandDengMeichundengmch@csu.edu.cnab⁎[a], [b], [c], [d], ⁎Corresponding author. Tel.: +86 731"/>
 <result pre="remain unknown. To effectively implement epidemic prevention, early identification and" exact="diagnosis" post="are critical to disease control. Here we scrutinise a"/>
 <result pre="of available studies by global scientists on the clinical manifestations," exact="detection" post="methods and treatment options for the disease caused by"/>
 <result pre="by global scientists on the clinical manifestations, detection methods and" exact="treatment" post="options for the disease caused by SARS-CoV-2, named coronavirus"/>
 <result pre="aetiological investigations by several independent laboratories in China. Following the" exact="isolation" post="of the new coronavirus, it was found to be"/>
 <result pre="estimated mortality rate of 2–5%. Person-to-person transmission may occur through" exact="contact" post="and respiratory transmission or possibly by the faecal–oral route."/>
 <result pre="infections has been increasing daily but there is no definite" exact="treatment" post="for COVID-19 pneumonia, although some potential drugs are under"/>
 <result pre="the bat coronavirus by accumulating favourable genetic alterations for human" exact="infection" post="[10]. Epitopes in SAR-CoV-2 structural proteins were differentially recognised"/>
 <result pre="confirmed and most of them had a history of close" exact="contact" post="with the epidemic area or with confirmed patients. Major"/>
 <result pre="digestive system and nervous system, which increases the difficulty of" exact="diagnosis" post="[16]. In this study, the median interval from the"/>
 <result pre="with previous reports [18]. According to the newly released pneumonitis" exact="diagnosis" post="and treatment plan for novel coronavirus infection, severe patients"/>
 <result pre="reports [18]. According to the newly released pneumonitis diagnosis and" exact="treatment" post="plan for novel coronavirus infection, severe patients often have"/>
 <result pre="are relatively mild. Regarding the current situation, the source of" exact="infection" post="is mainly infected patients, but the possibility of asymptomatic"/>
 <result pre="infection is mainly infected patients, but the possibility of asymptomatic" exact="infection" post="should not be ignored. Respiratory droplets and close contacts"/>
 <result pre="transcriptomes suggests that the digestive tract may serve as an" exact="infection" post="pathway for SARS-CoV-2. The spread and infection of the"/>
 <result pre="serve as an infection pathway for SARS-CoV-2. The spread and" exact="infection" post="of the virus are complex problems requiring co-operation from"/>
 <result pre="are often increased in severe and critical patients. 5.3.2 Molecular" exact="diagnosis" post="Real-time reverse transcription PCR (RT-PCR) Samples from suspected SARS-CoV-2"/>
 <result pre="of control can lead to false-positive results. In addition, RT-PCR" exact="tests" post="may be falsely negative due to insufficient viral material"/>
 <result pre="findings for COVID-19, meaning that PCR results can assist clinical" exact="diagnosis" post="and evaluation but the possibility of the disease cannot"/>
 <result pre="RT-PCR screening, a combination of CT scanning and repeated swab" exact="tests" post="may be helpful [27]. SHERLOCK technique The CRISPR-based SHERLOCK"/>
 <result pre="High-sensitivity Enzymatic Reporter UnLOCKing) technique allows portable, multiplexed and ultrasensitive" exact="detection" post="of RNA or DNA from clinically relevant samples. SHERLOCK"/>
 <result pre="pre-amplification of DNA or RNA and subsequent Cas13- or Cas12-mediated" exact="detection" post="via colorimetric read-outs and fluorescence that provide results in"/>
 <result pre="fusion inhibitor denoted EK1 that can significantly inhibit SARS-CoV-2 pseudovirus" exact="infection" post="in a dose-dependent manner [60]. 8 Treatment strategies 8.1"/>
 <result pre="and organisations in China have issued several guidelines for the" exact="diagnosis" post="and treatment of novel coronavirus pneumonia, none of which"/>
 <result pre="in China have issued several guidelines for the diagnosis and" exact="treatment" post="of novel coronavirus pneumonia, none of which recommended specific"/>
 <result pre="which recommended specific drugs for COVID-19. According to the latest" exact="treatment" post="protocol (Pilot Version 6) issued by the National Health"/>
 <result pre="that in the Vero E6 cell model, remdesivir inhibits the" exact="infection" post="of SARS-CoV-2 virus, with an EC50 (half-maximal effective concentration)"/>
 <result pre="new coronavirus pneumonia treated in the USA received only supportive" exact="treatment" post="for nausea, vomiting and other symptoms at the initial"/>
 <result pre="broad-spectrum antiviral nucleoside analogue that has been used in the" exact="treatment" post="of hepatitis C virus and respiratory syncytial virus. The"/>
 <result pre="Thus, TMPRSS2 inhibitors are also considered as drugs for the" exact="treatment" post="of novel coronavirus pneumonia [81]. 8.1.3 Broad-spectrum antivirals Interferon"/>
 <result pre="Due to the similar RBD structures of SARS-CoV-2 and SARS-CoV," exact="screening" post="anti-SARS-CoV antibodies will facilitate the rapid development of monoclonal"/>
 <result pre="in combination with other neutralising antibodies for the prevention and" exact="treatment" post="of SARS-CoV-2 infection [37]. However, the dose needs to"/>
 <result pre="other neutralising antibodies for the prevention and treatment of SARS-CoV-2" exact="infection" post="[37]. However, the dose needs to be determined before"/>
 <result pre="critically ill patients has been included in the latest Chinese" exact="treatment" post="protocol (Pilot Version 6). One meta-analysis showed that glucocorticoids"/>
 <result pre="is likely to reduce the damage in patients with SARS-CoV-2" exact="infection" post="[88]. XueBiJing is a traditional Chinese medicine injection commonly"/>
 <result pre="for potential Chinese medicines for COVID-19. 9 Prevention 9.1 Traveller" exact="screening" post="Traveller screening is a way to limit the further"/>
 <result pre="Chinese medicines for COVID-19. 9 Prevention 9.1 Traveller screening Traveller" exact="screening" post="is a way to limit the further spread of"/>
 <result pre="with the aim of curtailing the geographic spread of the" exact="infection" post="[90]. Traveller symptom screening depends on the natural history"/>
 <result pre="curtailing the geographic spread of the infection [90]. Traveller symptom" exact="screening" post="depends on the natural history of the infection. Individuals"/>
 <result pre="show detectable symptoms with increasing time since exposure. However, traveller" exact="screening" post="is also limited. Gostic et al. performed tests to"/>
 <result pre="However, traveller screening is also limited. Gostic et al. performed" exact="tests" post="to estimate the effectiveness of traveller screening and found,"/>
 <result pre="et al. performed tests to estimate the effectiveness of traveller" exact="screening" post="and found, within the narrow range of the tests,"/>
 <result pre="found, within the narrow range of the tests, that traveller" exact="screening" post="outcomes were sensitive at a short mean incubation period"/>
 <result pre="find theoretical reasons to support this method for preventing viral" exact="infection" post="with SARS-CoV-2, Fan et al. discussed from the perspective"/>
 <result pre="ACE2 receptor and exerting an antiviral effect to prevent SARS-CoV-2" exact="infection" post="[96]. 10 Conclusion SARS-CoV-2 is driving China's urgent public"/>
 <result pre="2019 novel coronavirus in Wuhan, ChinaLancet395202049750610.1016/s0140-6736(20)30183-531986264 19ZhouY.YangL.HanM.HuangM.SunX.ZhenW.Clinical reports on early" exact="diagnosis" post="of novel coronavirus (2019-nCoV) pneumonia in stealth infected patientsPreprints2020202002015610.20944/preprints202002.0156.v1"/>
 <result pre="single-cell transcriptomesbioRxiv2020 Jan 3110.1101/2020.01.30.927806 22JinY.H.CaiL.ChengZ.S.ChengH.DengT.FanY.P.A rapid advice guideline for the" exact="diagnosis" post="and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia"/>
 <result pre="Jan 3110.1101/2020.01.30.927806 22JinY.H.CaiL.ChengZ.S.ChengH.DengT.FanY.P.A rapid advice guideline for the diagnosis and" exact="treatment" post="of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)Mil"/>
 <result pre="Med Res72020410.1186/s40779-020-0233-632029004 23ShenK.YangY.WangT.ZhaoD.JiangY.JinR.Diagnosis, treatment, and prevention of 2019 novel coronavirus" exact="infection" post="in children: experts' consensus statementWorld J Pediatr2020 Feb 710.1007/s12519-020-00343-7[Epub"/>
 <result pre="for a pneumonia outbreak originating in Wuhan, ChinaMicrobes Infect222020747910.1016/j.micinf.2020.01.00332017984 26ChuD.K.W.PanY.ChengS.M.S.HuiK.P.Y.KrishnanP.LiuY.Molecular" exact="diagnosis" post="of a novel coronavirus (2019-nCoV) causing an outbreak of"/>
 <result pre="2019-nCoV pneumonia: relationship to negative RT-PCR testingRadiology202020034310.1148/radiol.2020200343 28KellnerM.J.KoobJ.G.GootenbergJ.S.AbudayyehO.O.ZhangF.SHERLOCK: nucleic acid" exact="detection" post="with CRISPR nucleasesNat Protoc1420192986301210.1038/s41596-019-0210-2Erratum in: Nat Protoc 2020;15:1311. doi:"/>
 <result pre="virus in rhesus monkeysNature531201638138510.1038/nature1718026934220 64de WitE.FeldmannF.CroninJ.JordanR.OkumuraA.ThomasT.Prophylactic and therapeutic remdesivir (GS-5734)" exact="treatment" post="in the rhesus macaque model of MERS-CoV infectionProc Natl"/>
 <result pre="(RdRp): a molecular docking studyLife Sci202011759210.1016/j.lfs.2020.117592 68ShenL.YangY.YeF.LiuG.DesforgesM.TalbotP.J.Safe and sensitive antiviral" exact="screening" post="platform based on recombinant human coronavirus OC43 expressing the"/>
 <result pre="systematic review and meta-analysisRev Med Virol282018e197710.1002/rmv.197729664167 73StockmanL.J.BellamyR.GarnerP.SARS: systematic review of" exact="treatment" post="effectsPLoS Med32006e34310.1371/journal.pmed.003034316968120 74MeynardJ.L.MoinotL.LandmanR.Morand-JoubertL.BesseghirA.KoltaS.Week 96 efficacy of lopinavir/ritonavir monotherapy in"/>
 <result pre="e00420-17 76ChanJ.F.YaoY.YeungM.L.DengW.BaoL.JiaL.Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV" exact="infection" post="in a nonhuman primate model of common marmosetJ Infect"/>
 <result pre="of the index patient who caused tertiary transmission of COVID-19" exact="infection" post="in Korea: the application of lopinavir/ritonavir for the treatment"/>
 <result pre="COVID-19 infection in Korea: the application of lopinavir/ritonavir for the" exact="treatment" post="of COVID-19 infected pneumonia monitored by quantitative RT-PCRJ Korean"/>
 <result pre="of print] 83VincentM.J.BergeronE.BenjannetS.EricksonB.R.RollinP.E.KsiazekT.G.Chloroquine is a potent inhibitor of SARS coronavirus" exact="infection" post="and spreadVirol J220056910.1186/1743-422x-2-6916115318 84SavarinoA.Di TraniL.DonatelliI.CaudaR.CassoneA.New insights into the antiviral"/>
 <result pre="Wei Zhong Bing Ji Jiu Yi Xue3120191199120310.3760/cma.j.issn.2095-4352.2019.10.00431771714 90GosticK.M.KucharskiA.J.Lloyd-SmithJ.O.Effectiveness of traveller" exact="screening" post="for emerging pathogens is shaped by epidemiology and natural"/>
 <result pre="A.C.R., Mummah R.O., Kucharski A.J., Lloyd-Smith J.O.Estimated effectiveness of traveller" exact="screening" post="to prevent international spread of 2019 novel coronavirus (2019-nCoV)"/>
</results>
